TSS
ORTX

Two Sigma Securities’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Two Sigma Securities’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,536
Closed -$9.41K – 3450
2022
Q4 		$9.41K Buy
2,536
+1,153
+83% +$5.1K ﹤0.01% 2370
2022
Q3 		$7K Buy
+1,383
New +$7.7K ﹤0.01% 2452
2022
Q1 		– Sell
-4,631
Closed -$61K – 2637
2021
Q4 		$61K Buy
+4,631
New +$76.6K ﹤0.01% 1248

Other funds holding ORTX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Securities's ORTX Position: Q1 2023 in Review

Two Sigma Securities sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 2,536 shares — an estimated $9.41K sold.

Two Sigma Securities first reported a position in ORTX in Q4 2021 and held it in 3 quarters. The position peaked at $61K in Q4 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

  • Two Sigma Securities reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 2,536 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $9.41K.
  • Two Sigma Securities first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Two Sigma Securities's Orchard Therapeutics plc American Depositary Shares position peaked at $61K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.